Concerns about HAART (Highly Active Anti-Retroviral Therapy)

Alberta Reappraising AIDS Society

David R. Crowe, President
Phone: +1-403-289-6609
Fax: +1-403-206-7717
Email: David.Crowe@aras.ab.ca

Roger Swan, Treasurer
Box 61037, Kensington Postal Outlet
Calgary, Alberta T2N 4S6
Canada
Office
Phone: +1-403-220-0129
Email: aras@aras.ab.ca
Web: noaids.ca

Concerns about HAART (Highly Active Anti-Retroviral Therapy)

Resistance to Therapy

Resistance to therapy is often blamed for the inability of AIDS therapy to affect 'surrogate markers', such as CD4 counts and viral load used to monitor the progress of therapy. Resistance is very difficult to accurately measure, but is a convenient scapegoat. Furthermore, even when therapy does affect surrogate markers in the hoped-for manner it doesn't necessarily result in better health (but that's a different issue).

Search
Help
ExportZero records

Feedback

We appreciate your comments, feedback, questions and suggestions for improvements to this site. Click here to send us a message.

© Copyright February 15, 2016: Alberta Reappraising AIDS Society